Calcium channel blocker use and risk of prostate cancer by TMPRSS2:ERG gene fusion status.

Calcium channel blocker use and risk of prostate cancer by TMPRSS2:ERG gene fusion status.

<h4>Background</h4> <p>Calcium channel blockers (CCBs) may affect prostate cancer (PCa) growth by various mechanisms including those related to androgens. The fusion of the androgen-regulated gene TMPRSS2 and the oncogene ERG (TMPRSS2:ERG or T2E) is common in PCa, and prostate tum...

Full description

Bibliographic Details
Main Authors:	Geybels, MS, McCloskey, KD, Mills, IG, Stanford, JL
Format:	Journal article
Language:	English
Published:	Wiley 2016

Similar Items

Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
by: Scott A. Tomlins, et al.
Published: (2008-02-01)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
by: Francesca Giunchi, et al.
Published: (2020-12-01)

CORRELATION OF TMPRSS2-ERG GENE FUSION STATUS WITH CLINICOPATHOLOGICAL CHARACTERISTICS IN PROSTATE CANCER OF IRAQI PATIENTS
by: Ammar K. A., et al.
Published: (2022-06-01)

Detection of tmprss2-erg and tmprss2-egr1 gene fusion in prostate cancer from a Chinese population
by: Changqing Xu, et al.
Published: (2020-12-01)

Identification of novel somatic fusions of ERG‐VEGFA, TMPRSS2‐ERG, and VEGFA‐TMPRSS2 in prostate cancer treated with anlotinib and androgen deprivation therapy: A case report
by: Qiuli Liu, et al.
Published: (2022-06-01)

Status of TMPRSS2–ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism
by: Aparna Bhanushali, et al.
Published: (2018-12-01)

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature
by: Yawei Li, et al.
Published: (2024-02-01)

5' UTR control of native ERG and of Tmprss2:ERG variants activity in prostate cancer.
by: Francesca Zammarchi, et al.
Published: (2013-01-01)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2021-06-01)

Height, Obesity, and the Risk of TMPRSS2:ERG-Defined Prostate Cancer
by: Graff, Rebecca E., et al.
Published: (2022)

Height, obesity, and the risk of TMPRSS2:ERG -defined prostate cancer
by: Graff, Rebecca E, et al.
Published: (2021)

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
by: Laura E Pascal, et al.
Published: (2016-01-01)

TMPRSS2-ERG Gene Fusion Causing ERG Overexpression Precedes Chromosome Copy Number Changes in Prostate Carcinomas, Paired HGPIN Lesions
by: Nuno Cerveira, et al.
Published: (2006-10-01)

Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.
by: Lihong Yin, et al.
Published: (2011-01-01)

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
by: Jack A. Schalken, et al.
Published: (2010-07-01)

TMPRSS2: ERG expression in prostate cancer: Imaging and clinico-pathological correlations
by: V. Fasulo, et al.
Published: (2020-10-01)

CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation
by: McKerr, N, et al.
Published: (2023)

Impact of TMPRSS2-ERG fusion gene on prostate cancer cell response to chemotherapy, radiotherapy and androgen deprivation therapy
by: Ovtcharov, S
Published: (2015)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
by: Kluth M, et al.
Published: (2018-11-01)

Detailed molecular and immune marker profiling of archival prostate cancer samples reveals an inverse association between TMPRSS2:ERG fusion status and immune cell infiltration
by: Rao, SR, et al.
Published: (2020)

PCA3 and TMPRSS2: ERG Urine Level as Diagnostic Biomarker of Prostate Cancer
by: Warli SM, et al.
Published: (2023-05-01)

A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma
by: Emily Zhou, et al.
Published: (2020-12-01)

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer.
by: Longjiang Shao, et al.
Published: (2013-01-01)

TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
by: Louie Semaan, et al.
Published: (2019-10-01)

Transcriptome Profiling of Prostate Cancer, Considering Risk Groups and the TMPRSS2-ERG Molecular Subtype
by: Anastasiya A. Kobelyatskaya, et al.
Published: (2023-05-01)

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer.
by: Giorgia Urbinati, et al.
Published: (2015-01-01)

Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement
by: Maisa Yoshimoto, et al.
Published: (2006-06-01)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
by: Christoph Fraune, et al.
Published: (2020-03-01)

Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide
by: Giorgia Urbinati, et al.
Published: (2016-01-01)

<it>TMPRSS2-ERG </it>-specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
by: Brase Jan C, et al.
Published: (2011-12-01)

Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
by: Douglas E Linn, et al.
Published: (2015-01-01)

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status
by: Caterina Mancarella, et al.
Published: (2017-05-01)

Molecular Characterization of TMPRSS2-ERG Gene Fusion in the NCI-H660 Prostate Cancer Cell Line: A New Perspective for an Old Model
by: Kirsten D. Mertz, et al.
Published: (2007-03-01)

Hyperglycemia Promotes TMPRSS2-ERG Gene Fusion in Prostate Cancer Cells via Upregulating Insulin-Like Growth Factor-Binding Protein-2
by: Jeff M. P. Holly, et al.
Published: (2017-11-01)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
by: Massimo Lazzeri, et al.
Published: (2022-09-01)

Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer
by: Qiong Wang, et al.
Published: (2022-09-01)

SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
by: Carlos D. Cruz-Hernández, et al.
Published: (2020-07-01)

BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
by: Xiangyi Li, et al.
Published: (2018-01-01)

Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against <i>TMPRSS2-ERG</i> (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer
by: Komal Raina, et al.
Published: (2023-10-01)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
by: Vipulkumar Dadhania, et al.
Published: (2022-05-01)